Literature DB >> 8361471

[Modes of spread and surgical strategy for gallbladder carcinoma with subserosal invasion].

T Izumi1, H Shimada, M Maehara, K Katayama, M Note, H Seki, G Nakagawara.   

Abstract

The mode of spread and the prognosis were investigated in 22 patients with resected gallbladder carcinoma invading the subserosal layer. By the Kaplan-Meier method, the 5-year survival rate was 68.8% in patients receiving curative or relatively noncurative resection. On the other hand, no patient survived for more than 3 years after noncurative resection. The mode of subserosal infiltration was classified according to the general rules for gastric cancer study. At least systemic lymph node dissection (R2) should be performed in patients with ss alpha cancer, because lymph node metastasis in these patients were confined to the 1st group. More extensive lymph node dissection (R2 with 9, 16) is essential for patients with ss beta and ss gamma, because lymph node metastasis to at least the 2nd group were seen in 75% of them. The surgical margin was positive for cancer in all patient with infiltration of the hepatoduodenal ligament. Therefore, it was considered that hepatoligamentectomy should be performed in these patients to obtain a cancer free surgical margin. Among patients undergoing curative or relatively noncurative resection, the recurrence rate was 43% in those with lymph node metastasis and 50% in those with DNA aneuploidy. Therefore, it appears that adjuvant chemotherapy should be given to such patients.

Entities:  

Mesh:

Year:  1993        PMID: 8361471

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  2 in total

1.  Extended cholecystectomy for carcinoma of the gallbladder.

Authors:  H Onoyama; M Yamamoto; A Tseng; T Ajiki; Y Saitoh
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

2.  Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C.

Authors:  Qiang Du; Lei Jiang; Xiaoqian Wang; Meiping Wang; Feifei She; Yanling Chen
Journal:  Cancer Sci       Date:  2014-10-09       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.